Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors

Aleman, Fernando; Tzarum, Netanel; Kong, Leopold; Nagy, Kenna; Zhu, Jiang; Wilson, Ian A.; Law, Mansun

doi:10.1073/pnas.1802378115

Title: Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors

Journal Article · Thu Jun 28 00:00:00 EDT 2018 · Proceedings of the National Academy of Sciences of the United States of America

DOI:https://doi.org/10.1073/pnas.1802378115· OSTI ID:1497190

^[1]; Tzarum, Netanel ^[1]; Kong, Leopold ^[1]; Nagy, Kenna ^[1]; Zhu, Jiang ^[1]; Wilson, Ian A. ^[1]; Law, Mansun ^[1]

The Scripps Research Inst., La Jolla, CA (United States)

Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine design against antigenically diverse pathogens. Here, we studied a panel of monoclonal antibodies (mAbs) from mice immunized with the hepatitis C virus (HCV) envelope glycoproteins E1E2. Six of the mAbs recognize the conserved E2 antigenic site 412–423 (AS412) and cross-neutralize diverse HCV genotypes. Immunogenetic and structural analysis revealed that the antibodies originated from two different germline (GL) precursors and bind AS412 in a β-hairpin conformation. Intriguingly, the anti-HCV activity of one antibody lineage is associated with maturation of the light chain (LC), whereas the other lineage is dependent on heavy-chain (HC) maturation. Crystal structures of GL precursors of the LC-dependent lineage in complex with AS412 offer critical insights into the maturation process of bnAbs to HCV, thus providing a scientific foundation for utilizing the mouse model to study AS412-targeting vaccine candidates.

View Accepted Manuscript (DOE)

Cite

Export

Save

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES); USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institute of General Medical Sciences (NIGMS); National Center for Research Resources

Grant/Contract Number:: AI079031; AI106005; AI123365; AI123861; AC02-06CH11357

OSTI ID:: 1497190

Report Number(s):: 29637

Journal Information:: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Issue 29; ISSN 0027-8424

Publisher:: National Academy of SciencesCopyright Statement

Country of Publication:: United States

Language:: ENGLISH

Citation Metrics:

Cited by: 9 works

Citation information provided by
Web of Science

References (47)

Hepatitis C Virus E2 Envelope Glycoprotein Core Structure Kong, L.; Giang, E.; Nieusma, T. Science, Vol. 342, Issue 6162 https://doi.org/10.1126/science.1243876	journal	November 2013
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein Owsianka, A.; Tarr, A. W.; Juttla, V. S. Journal of Virology, Vol. 79, Issue 17 https://doi.org/10.1128/JVI.79.17.11095-11104.2005	journal	August 2005
Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis Gopal, Radhika; Jackson, Kelli; Tzarum, Netanel PLOS Pathogens, Vol. 13, Issue 12 https://doi.org/10.1371/journal.ppat.1006735	journal	December 2017
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees Morin, Trevor J.; Broering, Teresa J.; Leav, Brett A. PLoS Pathogens, Vol. 8, Issue 8 https://doi.org/10.1371/journal.ppat.1002895	journal	August 2012
Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate Keck, Zhen-yong; Xia, Jinming; Wang, Yong PLoS Pathogens, Vol. 8, Issue 4 https://doi.org/10.1371/journal.ppat.1002653	journal	April 2012
Structure of Hepatitis C Virus Envelope Glycoprotein E2 Antigenic Site 412 to 423 in Complex with Antibody AP33 Kong, L.; Giang, E.; Nieusma, T. Journal of Virology, Vol. 86, Issue 23 https://doi.org/10.1128/JVI.01939-12	journal	September 2012
Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding Owsianka, A. M.; Timms, J. M.; Tarr, A. W. Journal of Virology, Vol. 80, Issue 17 https://doi.org/10.1128/JVI.00271-06	journal	August 2006
Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study: Monoclonal Antibody to HCV in Liver Transplantation Chung, R. T.; Gordon, F. D.; Curry, M. P. American Journal of Transplantation, Vol. 13, Issue 4 https://doi.org/10.1111/ajt.12083	journal	January 2013
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus Giang, E.; Dorner, M.; Prentoe, J. C. Proceedings of the National Academy of Sciences, Vol. 109, Issue 16 https://doi.org/10.1073/pnas.1114927109	journal	April 2012
Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody Potter, J. A.; Owsianka, A. M.; Jeffery, N. Journal of Virology, Vol. 86, Issue 23 https://doi.org/10.1128/JVI.02052-12	journal	September 2012
Computational tools for epitope vaccine design and evaluation He, Linling; Zhu, Jiang Current Opinion in Virology, Vol. 11 https://doi.org/10.1016/j.coviro.2015.03.013	journal	April 2015
Structural basis for germline antibody recognition of HIV-1 immunogens Scharf, Louise; West, Anthony P.; Sievers, Stuart A. eLife, Vol. 5 https://doi.org/10.7554/eLife.13783	journal	March 2016
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus Broering, T. J.; Garrity, K. A.; Boatright, N. K. Journal of Virology, Vol. 83, Issue 23 https://doi.org/10.1128/JVI.01138-09	journal	September 2009
Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2 Owsianka, Ania; Clayton, Reginald F.; Loomis-Price, Lawrence D. Journal of General Virology, Vol. 82, Issue 8 https://doi.org/10.1099/0022-1317-82-8-1877	journal	August 2001
Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies Fauvelle, Catherine; Colpitts, Che C.; Keck, Zhen-yong Expert Review of Vaccines, Vol. 15, Issue 12 https://doi.org/10.1080/14760584.2016.1194759	journal	May 2016
Broadly neutralizing antibodies abrogate established hepatitis C virus infection de Jong, Y. P.; Dorner, M.; Mommersteeg, M. C. Science Translational Medicine, Vol. 6, Issue 254 https://doi.org/10.1126/scitranslmed.3009512	journal	September 2014
Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein Is a Mechanism for Escape from Broadly Neutralizing Antibodies Pantua, Homer; Diao, Jingyu; Ultsch, Mark Journal of Molecular Biology, Vol. 425, Issue 11 https://doi.org/10.1016/j.jmb.2013.02.025	journal	June 2013
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1 Kong, L.; Giang, E.; Robbins, J. B. Proceedings of the National Academy of Sciences, Vol. 109, Issue 24 https://doi.org/10.1073/pnas.1202924109	journal	May 2012
Amino Acid Residue-Specific Neutralization and Nonneutralization of Hepatitis C Virus by Monoclonal Antibodies to the E2 Protein Duan, H.; Kachko, A.; Zhong, L. Journal of Virology, Vol. 86, Issue 23 https://doi.org/10.1128/JVI.00994-12	journal	September 2012
Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design Kong, Leopold; Jackson, Kelli N.; Wilson, Ian A. Current Opinion in Virology, Vol. 11 https://doi.org/10.1016/j.coviro.2015.04.001	journal	April 2015
Strategies to guide the antibody affinity maturation process Doria-Rose, Nicole A.; Joyce, M. Gordon Current Opinion in Virology, Vol. 11 https://doi.org/10.1016/j.coviro.2015.04.002	journal	April 2015
Generation and Characterization of Monoclonal Antibodies against a Cyclic Variant of Hepatitis C Virus E2 Epitope 412-422 Sandomenico, Annamaria; Leonardi, Antonio; Berisio, Rita Journal of Virology, Vol. 90, Issue 7 https://doi.org/10.1128/JVI.02397-15	journal	January 2016
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge Law, Mansun; Maruyama, Toshiaki; Lewis, Jamie Nature Medicine, Vol. 14, Issue 1 https://doi.org/10.1038/nm1698	journal	December 2007
Viral evasion and challenges of hepatitis C virus vaccine development Pierce, Brian G.; Keck, Zhen-Yong; Foung, Steven KH Current Opinion in Virology, Vol. 20 https://doi.org/10.1016/j.coviro.2016.09.004	journal	October 2016
Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen Kong, Leopold; Lee, David E.; Kadam, Rameshwar U. Proceedings of the National Academy of Sciences, Vol. 113, Issue 45 https://doi.org/10.1073/pnas.1609780113	journal	October 2016
The past, present and future of neutralizing antibodies for hepatitis C virus Ball, Jonathan K.; Tarr, Alexander W.; McKeating, Jane A. Antiviral Research, Vol. 105 https://doi.org/10.1016/j.antiviral.2014.02.013	journal	May 2014
Structural Basis for Penetration of the Glycan Shield of Hepatitis C Virus E2 Glycoprotein by a Broadly Neutralizing Human Antibody Li, Yili; Pierce, Brian G.; Wang, Qian Journal of Biological Chemistry, Vol. 290, Issue 16 https://doi.org/10.1074/jbc.M115.643528	journal	March 2015
Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization Tarr, A. W.; Urbanowicz, R. A.; Jayaraj, D. Journal of Virology, Vol. 86, Issue 5 https://doi.org/10.1128/JVI.06492-11	journal	December 2011
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen Jardine, J. G.; Kulp, D. W.; Havenar-Daughton, C. Science, Vol. 351, Issue 6280 https://doi.org/10.1126/science.aad9195	journal	March 2016
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires Tian, Ming; Cheng, Cheng; Chen, Xuejun Cell, Vol. 166, Issue 6 https://doi.org/10.1016/j.cell.2016.07.029	journal	September 2016
Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles Wasilewski, Lisa N.; Ray, Stuart C.; Bailey, Justin R. Journal of General Virology, Vol. 97, Issue 11 https://doi.org/10.1099/jgv.0.000608	journal	November 2016
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma Zhang, P.; Wu, C. G.; Mihalik, K. Proceedings of the National Academy of Sciences, Vol. 104, Issue 20 https://doi.org/10.1073/pnas.0703039104	journal	May 2007
Murine models of hepatitis C: What can we look forward to? von Schaewen, Markus; Ploss, Alexander Antiviral Research, Vol. 104 https://doi.org/10.1016/j.antiviral.2014.01.007	journal	April 2014
The Hepatitis C Virus Glycan Shield and Evasion of the Humoral Immune Response Helle, François; Duverlie, Gilles; Dubuisson, Jean Viruses, Vol. 3, Issue 10 https://doi.org/10.3390/v3101909	journal	October 2011
Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope Pierce, Brian G.; Boucher, Elisabeth N.; Piepenbrink, Kurt H. Journal of Virology, Vol. 91, Issue 20 https://doi.org/10.1128/JVI.01032-17	journal	August 2017
Structural Flexibility of a Conserved Antigenic Region in Hepatitis C Virus Glycoprotein E2 Recognized by Broadly Neutralizing Antibodies Meola, Annalisa; Tarr, Alexander W.; England, Patrick Journal of Virology, Vol. 89, Issue 4 https://doi.org/10.1128/JVI.02190-14	journal	December 2014
Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate A., Rey, Felix; Ying-Jian, Li, Angela; Jannick, Prentoe, The University of North Carolina at Chapel Hill University Libraries https://doi.org/10.17615/24v1-w392	text	January 2012
Fine Mapping of Murine Antibody Responses to Immunization with a Novel Soluble Form of Hepatitis C Virus Envelope Glycoprotein Complex Ruwona, T. B.; Giang, E.; Nieusma, T. Journal of Virology, Vol. 88, Issue 18 https://doi.org/10.1128/JVI.01584-14	journal	June 2014
Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies Pedersen, Jannie; Carlsen, Thomas H. R.; Prentoe, Jannick Hepatology, Vol. 58, Issue 5 https://doi.org/10.1002/hep.26524	journal	August 2013
Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge: Desombere et al. Desombere, Isabelle; Fafi-Kremer, Samira; Van Houtte, Freya Hepatology, Vol. 63, Issue 4 https://doi.org/10.1002/hep.28428	journal	February 2016
Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region Alhammad, Yousef; Gu, Jun; Boo, Irene Journal of Virology, Vol. 89, Issue 24 https://doi.org/10.1128/JVI.02070-15	journal	September 2015
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies Steichen, Jon M.; Kulp, Daniel W.; Tokatlian, Talar Immunity, Vol. 45, Issue 3 https://doi.org/10.1016/j.immuni.2016.08.016	journal	September 2016
Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding He, Linling; Cheng, Yushao; Kong, Leopold Scientific Reports, Vol. 5, Issue 1 https://doi.org/10.1038/srep12501	journal	August 2015
Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33 Tarr, A. W.; Owsianka, A. M.; Jayaraj, D. Journal of General Virology, Vol. 88, Issue 11 https://doi.org/10.1099/vir.0.83065-0	journal	November 2007
Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a Carlsen, Thomas H. R.; Pedersen, Jannie; Prentoe, Jannick C. Hepatology, Vol. 60, Issue 5 https://doi.org/10.1002/hep.27298	journal	October 2014
Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein Keck, Z.; Wang, W.; Wang, Y. Journal of Virology, Vol. 87, Issue 1 https://doi.org/10.1128/JVI.01941-12	journal	October 2012
Antibody Structure Stanfield, Robyn L.; Wilson, Ian A. Microbiology Spectrum, Vol. 2, Issue 2 https://doi.org/10.1128/microbiolspec.AID-0012-2013	journal	March 2014

Cited By (2)

Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder Yost, Samantha A.; Wang, Yuanyuan; Marcotrigiano, Joseph Frontiers in Immunology, Vol. 9 https://doi.org/10.3389/fimmu.2018.01917	journal	August 2018
Flexibility and intrinsic disorder are conserved features of hepatitis C virus E2 glycoprotein Stejskal, Lenka; Lees, William D.; Moss, David S. PLOS Computational Biology, Vol. 16, Issue 2 https://doi.org/10.1371/journal.pcbi.1007710	journal	February 2020

Similar Records

Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1

Journal Article · Mon Oct 29 00:00:00 EDT 2012 · Proc. Natl. Acad. Sci. USA · OSTI ID:1497190

Kong, Leopold; Giang, Erick; Robbins, Justin B; +4 more

HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage

Journal Article · Wed Nov 01 00:00:00 EDT 2017 · Immunity · OSTI ID:1497190

Landais, Elise; Murrell, Ben; Briney, Bryan; +22 more

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial

Journal Article · Fri Feb 24 00:00:00 EST 2017 · PLoS Pathogens · OSTI ID:1497190

Easterhoff, David; Moody, M. Anthony; Fera, Daniela; +29 more

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
hepatitis C Virus
broadly neutralizing antibodies
antibody germline precursors
HCV vaccine
E1E2 glycoproteins

Title: Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors

Citation Formats

References (47)

Cited By (2)

Similar Records

Related Subjects